Heron Therapeutics, Inc.

Heron Therapeutics, Inc.verified

HRTX

Price:

$3.2

Market Cap:

$482.09M

Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor...[Read more]

Industry

Biotechnology

IPO Date

1987-08-26

Stock Exchange

NASDAQ

Ticker

HRTX

The PE Ratio as of May 2024 (TTM) for Heron Therapeutics, Inc. (HRTX) is -5.82

According to Heron Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.82. This represents a change of -42.79% compared to the average of -10.17 of the last 4 quarters.

Heron Therapeutics, Inc. (HRTX) Historical PE Ratio (quarterly & annually)

How has HRTX PE Ratio performed in the past?

The mean historical PE Ratio of Heron Therapeutics, Inc. over the last ten years is -5.72. The current -5.82 PE Ratio has changed 10.07% with respect to the historical average. Over the past ten years (40 quarters), HRTX's PE Ratio was at its highest in in the June 2023 quarter at -0.83. The PE Ratio was at its lowest in in the March 2024 quarter at -32.42.

Quarterly (TTM)
Annual

Average

-5.72

Median

-4.54

Minimum

-10.62

Maximum

-2.02

Heron Therapeutics, Inc. (HRTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Heron Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 158.59%

Maximum Annual PE Ratio = -2.02

Minimum Annual Increase = -68.30%

Minimum Annual PE Ratio = -10.62

Quarterly (TTM)
Annual
YearPE RatioChange
2023-2.124.97%
2022-2.02-51.01%
2021-4.13-51.75%
2020-8.56-8.80%
2019-9.39-11.59%
2018-10.62114.34%
2017-4.9572.61%
2016-2.87-68.30%
2015-9.05158.59%
2014-3.5033.01%

Heron Therapeutics, Inc. (HRTX) Average PE Ratio

How has HRTX PE Ratio performed in the past?

The current PE Ratio of Heron Therapeutics, Inc. (HRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-2.76

5-year avg

-5.24

10-year avg

-5.72

Heron Therapeutics, Inc. (HRTX) PE Ratio vs. Peers

How is HRTX’s PE Ratio compared to its peers?

Heron Therapeutics, Inc.’s PE Ratio is greater than Mereo BioPharma Group plc (-63.73), less than Terns Pharmaceuticals, Inc. (-4.82), less than PDS Biotechnology Corporation (-2.77), less than Inozyme Pharma, Inc. (-3.68), less than HOOKIPA Pharma Inc. (-2.15), less than X4 Pharmaceuticals, Inc. (-1.44), less than Acumen Pharmaceuticals, Inc. (-3.90), greater than Day One Biopharmaceuticals, Inc. (-6.71), less than Eledon Pharmaceuticals, Inc. (-2.27),

Build a custom stock screener for Heron Therapeutics, Inc. (HRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heron Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Heron Therapeutics, Inc. (HRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Heron Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Heron Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Heron Therapeutics, Inc. (HRTX)?

What is the highest PE Ratio for Heron Therapeutics, Inc. (HRTX)?

What is the 3-year average PE Ratio for Heron Therapeutics, Inc. (HRTX)?

What is the 5-year average PE Ratio for Heron Therapeutics, Inc. (HRTX)?

How does the current PE Ratio for Heron Therapeutics, Inc. (HRTX) compare to its historical average?